Oppenheimer & CO Inc Kala Pharmaceuticals, Inc. Transaction History

Oppenheimer & CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.25 - $0.36 $125 - $180	-500 Reduced 0.81%	61,600 $13,000
Q2 2022 Aug 08, 2022	BUY	$0.3 - $1.31 $9,900 - $43,230	33,000 Added 113.4%	62,100 $18,000
Q1 2022 May 12, 2022	BUY	$0.61 - $1.84 $610 - $1,840	1,000 Added 3.56%	29,100 $40,000
Q4 2021 Feb 02, 2022	SELL	$1.16 - $2.74 $14,963 - $35,346	-12,900 Reduced 31.46%	28,100 $34,000
Q3 2021 Nov 12, 2021	BUY	$2.62 - $5.43 $26,986 - $55,929	10,300 Added 33.55%	41,000 $107,000

Q2 2021 Aug 03, 2021	BUY	$5.06 - $8.15 $155,342 - $250,205	30,700 New	30,700 $163,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.4M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.